Keros Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $370.0M
Liabilities Breakdown FY2023
Total Liabilities: $37.8M
Asset Breakdown
Total Assets: $370.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $331.1M | 89.5% |
| Accounts Receivable | $143.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.1M | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $34.6M | 9.4% |
Liabilities Breakdown
Total Liabilities: $37.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.5M | 14.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $32.4M | 85.6% |